Incyte (INCY)

$59.00 1.58 (2.68%)

20:00 EDT INCY Stock Quote Delayed 30 Minutes

Vapid Earnings Visibility Restrict Incyte (INCY) Rating

By Portfolio Grader Nov 6, 2017

Incyte Corp (NASDAQ:INCY) is a $22.2 billion in market value member of the Biotechnology GICS industry group where Portfolio Grader's current ranking for INCY puts it 171 among the 349 companies in this industry group, placing it in the top half. INCY is ranked in the third quartile of the sector with a ranking of 402 among the 785 companies in the sector and number 2,601 in the 5000 company Portfolio Grader company universe.

5 of the Toughest Stocks to Withstand a Downturn

5 Biotech Stocks That Are Breaking Higher

Incyte Corporation (INCY) Shares Drop on Q2 Loss

Volume:

Previous Close $62.46

Market Cap 11.72B

PE Ratio 381.14

EPS 0.1548

Volume (Avg. Vol.) 3.67M

Day's Range $60.41 - $63.57

52-Week Range $50.35 - $83.95

Dividend & Yield N/A (N/A)

INCY Stock Predictions, Articles, and Incyte News

Why Herbalife Ltd. (HLF), Snap Inc (SNAP) and Incyte Corporation (INCY) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer Jun 5, 2017

Incyte (INCY), Snap (SNAP) and Herbalife (HLF) shareholders should have made it a three-day weekend. Here's why.

Incyte Corporation (INCY) Stock Jumps on Promising Lung Cancer Drug

By William White, InvestorPlace Writer May 18, 2017

Incyte (INCY) stock was up on Thursday on promising results in Phase 1 and Phase 2 studies for one of its lung cancer drugs.

4 Biotech Stocks That Could Be Rocked and Rolled This Month

By James Brumley, InvestorPlace Feature Writer May 4, 2017

If you own any of these biotech stocks (or are thinking about it), mark these four dates on your calendar. Things are going to get real interesting, real fast.

Why Dish Network Corp (DISH), Snyder’s-Lance Inc (LNCE) and Incyte Corporation (INCY) Are 3 of Today’s Worst Stocks

By James Brumley, InvestorPlace Feature Writer Apr 17, 2017

Incyte (INCY), Dish Network (DISH) and Snyder's-Lance (LNCE) shareholders ended up wishing this past weekend was a four-day trading break.

Eli Lilly and Co (LLY) Stock Holders Choke on FDA Letter for Barictinib

By Dana Blankenhorn, InvestorPlace Contributor Apr 17, 2017

Eli Lilly (LLY) took a hit Monday after an FDA letter on dosages and safety likely delayed Olumiant's U.S. market entry. But LLY stock still has its virtues.

The 10 Best Stocks of the S&P 500 in Q1

By Jeff Reeves Mar 31, 2017

While the markets have been performing well in general for the first quarter, some of the S&P 500's best stocks have really cut loose.

8 of the Most Overrated Stocks on Wall Street Right Now

By James Brumley, InvestorPlace Feature Writer Feb 27, 2017

Some stocks are graded fairly, but a handful of the most overrated stocks deserve to be called out -- and sold sooner than later.

37 Biotechnology Stocks to Sell Now

By Portfolio Grader Dec 26, 2016

This week, the overall grades of 37 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").